Clostridioides Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridioides Difficile Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: FQ Restriction for the Prevention of CDI
The clinical trial update notes that a study evaluating fluoroquinolone restriction to prevent Clostridioides difficile infection has comple…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Study of Clostridioides Difficile in Infants
This clinical trial is currently recruiting infants to study Clostridioides difficile infection.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection [Phase 2]
Phase 2 trial results for ACX-362E (Ibezapolstat) in treating Clostridioides difficile infection have been posted.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients [Phase 2]
Phase 2 clinical trial evaluating fecal microbiota transplantation for recurrent Clostridioides difficile infection in solid organ transplan…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Oral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection [Phase 3]
A Phase 3 clinical trial comparing oral vancomycin to placebo for preventing recurrence of Clostridioides difficile infection has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI [Phase 2]
Phase 2 ICON-2 trial comparing fecal microbiota transplantation plus bezlotoxumab versus fecal microbiota transplantation plus placebo in pa…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Study on Clostridium Difficile Infection in Infants
An infant-focused clinical trial investigating Clostridioides difficile infection is currently recruiting, with no results reported yet. The…
-
CLINICAL_TRIALS withdrawal · 2024-11-22Clinical Trial Update: Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections [NA]
The clinical trial evaluating Bacillus velezensis DSM 33864 to reduce recurrence of Clostridioides difficile infection has been withdrawn.
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Clostridioides Difficile Controlled Human Infection Model [NA]
Clinical trial update for a controlled human infection model study of Clostridioides difficile, sponsored by Leiden University Medical Cente…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection
The update describes a completed clinical trial evaluating novel biomarkers that may predict outcomes in patients with Clostridioides diffic…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection
A completed trial examined using bezlotoxumab alongside fecal microbiota transplantation for recurrent Clostridioides difficile infection.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population [Phase 4]
A Phase IIIB/IV trial comparing vancomycin to extended-duration fidaxomicin for clinical cure of Clostridioides difficile infection in older…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD) [Phase 3]
Phase 3 study comparing fidaxomicin (OPT-80) to vancomycin for safety and efficacy in Clostridioides difficile infection has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) [Phase 4]
A Phase 4 pharmacokinetic study evaluated fidaxomicin in patients with inflammatory bowel disease who have Clostridioides difficile infectio…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) [Phase 2]
Phase 2 clinical trial evaluating alanyl-glutamine supplementation for the treatment of Clostridioides difficile infection is currently recr…
-
EMA approval · 2024-09-30EMA Authorised: Dificlir (fidaxomicin) — Tillotts Pharma GmbH
The European Medicines Agency authorised Dificlir (fidaxomicin) for Clostridioides difficile infection, with Tillotts Pharma GmbH as the mar…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years [Phase 1]
Phase 1 safety and immunogenicity study of GlaxoSmithKline's Clostridioides difficile vaccine (2904545A) in healthy adults aged 18-45 and 50…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection [NA]
This ClinicalTrials.gov update reports completion of a trial evaluating lyophilized fecal microbiota transplantation for recurrent Clostridi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Fecal Transplantation for Primary Clostridium Difficile Infection [Phase 3]
Phase 3 trial evaluating fecal microbiota transplantation for primary Clostridioides difficile infection has been terminated.
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Safety and Efficacy of Fecal Microbiota Transplantation [NA]
A multicondition clinical trial evaluating fecal microbiota transplantation for various conditions; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Effects of Gastric Acid on Colonic Microbiome [Phase 4]
This Phase 4 trial examined how gastric acid influences the colonic microbiome in Clostridioides difficile infection. Results have been post…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Screening to Prophylax Against Clostridium Difficile Infection - [Phase 4]
A Phase 4 clinical trial evaluating screening-based prophylaxis to prevent Clostridioides difficile infection has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS) [Phase 3]
Phase 3 trial results for RBX2660, a microbiota restoration therapy, in recurrent Clostridioides difficile infection have been posted.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile Infection
A clinical trial evaluating gut microbiota and its associated resistome in fecal microbiota transplant donors and recipients for recurrent C…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: A Study to Assess the Effect of Doctor's Biome Medical Food in Individuals With Clostridium Difficile Infection [NA]
A clinical trial evaluating the effect of Doctor's Biome Medical Food in individuals with Clostridioides difficile infection, sponsored by V…